U.S. Markets closed

AstraZeneca’s Oncology Portfolio: Growth Trends in 2019

Margaret Patrick
AstraZeneca’s Oncology Portfolio: Growth Trends in 2019

Pfizer or AstraZeneca: Which Is a Better Pick in April?(Continued from Prior Part)Oncology portfolio growth trends During AstraZeneca’s (AZN) fourth-quarter earnings investor presentation, the company highlighted the potential of its oncology drug,